Why is collaboration between industry and academia necessary in the life sciences sector? What obstacles exist, and what is ...
When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on ...
When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on ...
Are you a pharmaceutical or biotech manufacturer preparing to commercialize a drug and wondering how to support your Phase ...
The Swedish national life science strategy was launched in December 2019, and it has now been updated with a new government ...
- Automation of complex in vitro model generation and quantification at scale - Brightfield and fluorescent imaging ...
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss syndrome, is characterised by an increased number of eosinophilic granulocytes in organs and in the bloodstream, ...
Svenskutvecklade alzheimerläkemedlet lecanemab (med handelsnamnet Leqembi) får ett positivt utlåtande från den europeiska läkemedelsmyndighetens kommitté för humanläkemedel, CHMP.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback